348249 <common-name>2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-phenyl-n-propan-2-ylacetamide</common-name> <description>2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-phenyl-n-propan-2-ylacetamide is a chemical compound with the formula C28H30N4OS2. With an average molecular weight of 502.70 g/mol, 2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-phenyl-n-propan-2-ylacetamide is a heavy molecule.</description> <cas>539811-51-3</cas> <pubchem-id>3869136</pubchem-id> <chemical-formula>C28H30N4OS2</chemical-formula> <weight>502.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T12:11:42Z</created-at> <updated-at type="dateTime">2026-08-31T12:11:42Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=C(C=C1)SCC2=NN=C(N2C3=CC=CC(=C3)C)SCC(=O)N(C4=CC=CC=C4)C(C)C</moldb-smiles> <moldb-formula>C28H30N4OS2</moldb-formula> <moldb-inchi>InChI=1S/C28H30N4OS2/c1-20(2)31(23-10-6-5-7-11-23)27(33)19-35-28-30-29-26(18-34-25-15-13-21(3)14-16-25)32(28)24-12-8-9-22(4)17-24/h5-17,20H,18-19H2,1-4H3</moldb-inchi> <moldb-inchikey>HQGVGTDPXPNITA-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">502.1861039</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM344142</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-phenyl-n-propan-2-ylacetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298584</sync-id> <structure-inchikey>HQGVGTDPXPNITA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000000000800000000800000000000000000100000000001000000000001080000002010004000000002084000000000000000000000000000000000000000000000000000000000000000020000000000000000000000010002000000000011010000000000000104000000000000100000000000800100004000001004140000000808200004000000000080000000100000010020001000000000000000000000010000000080000000000010004400000080000000400000000000000000000000000000000020000000000000000002000000200000000000000000140000000000040000000000480000000010200004040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB EAAgAAAAAgYAYAAAAAICBkAoAAAAAwQHQCgAAAADAwdAKAAAAAMDBkAoAAAA AwQHQCgAAAADAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMB BkAoAAAAAwQGQGgAAAADAwEGAGAAAAABAxAAIAAAAAIGAGAAAAACAgYAKAAA AAMECAAoAAAAAwIHACgAAAADAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB BkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBgBgAAAAAwEGAGAAAAABAwYA YAAAAAEDCwABAAECaAwCA2gMAwRoDAQFaAwFBmgMBAcABwgACAkACQpoDAoL aAwLDGgMDA1oDA0OIA4PaAwPEGgMEBFoDBESaAwSE2gMEhQADBUAFRYAFhcA FxgoAhcZIBkaIBobaAwbHGgMHB1oDB0eaAweH2gMGSAAICEAICIABgFoDA0J aAwTDmgMHxpoDEIEAAAABgEGBQQDAgUKCQ0MCwYPEBESEw4GGxwdHh8aFwQA AAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:41Z</structure-indexed-at> </compound>